TUSHAR MODI: Open Payments
NPI 1679551352 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 9 payments from 6 companies in 2025. Trend: 2023 $98 · 2024 $309 · 2025 $331
Education: $215Food & beverage: $66Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $170 |
| Abbott Laboratories | 3 | $84 |
| Lilly USA, LLC | 1 | $45 |
| PFIZER INC. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $4 |
Products named: FREESTYLE INSULINX, FREESTYLE LIBRE 3, PREVNAR 20, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
